Report a female diagnosed as type 1 Gaucher disease after a femoral pathologic fracture when she was 55 years old. Enzyme replacement therapy was started, and she achieved therapeutic goals. In 2015, a Ph’ CML with numerous pseudo‐Gaucher cells in bone marrow appears. BCR/ABL was not present at GD diagnosis.
CITATION STYLE
Noya, Ms., Andrade‐Campos, M., Irun, P., López de Frutos, L., López‐Fernandez, Mf., & Giraldo, P. (2018). Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously. Clinical Case Reports, 6(5), 887–892. https://doi.org/10.1002/ccr3.1460
Mendeley helps you to discover research relevant for your work.